Samsara BioCapital’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-35,349
| Closed | -$398K | – | 45 |
|
|
2023
Q2 | $398K | Hold |
35,349
| – | – | 0.07% | 40 |
|
|
2023
Q1 | $256K | Hold |
35,349
| – | – | 0.05% | 48 |
|
|
2022
Q4 | $398K | Hold |
35,349
| – | – | 0.09% | 45 |
|
|
2022
Q3 | $465K | Hold |
35,349
| – | – | 0.11% | 48 |
|
|
2022
Q2 | $446K | Hold |
35,349
| – | – | 0.12% | 49 |
|
|
2022
Q1 | $2.03M | Hold |
35,349
| – | – | 0.51% | 38 |
|
|
2021
Q4 | $4.2M | Hold |
35,349
| – | – | 0.81% | 24 |
|
|
2021
Q3 | $7.03M | Hold |
35,349
| – | – | 1.1% | 20 |
|
|
2021
Q2 | $6.15M | Hold |
35,349
| – | – | 0.76% | 23 |
|
|
2021
Q1 | $7M | Hold |
35,349
| – | – | 1.29% | 18 |
|
|
2020
Q4 | $6.96K | Hold |
35,349
| – | – | 0.7% | 16 |
|
|
2020
Q3 | $6.27M | Sell |
35,349
-3,351
| -9% | -$594K | 1.75% | 14 |
|
|
2020
Q2 | $8.95M | Buy |
+38,700
| New | +$8.95M | 2.88% | 11 |
|